|
|
|
Volumn 39, Issue 3, 2014, Pages 153-154
|
|
Pharmaceutical approval update
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
CREATININE;
DABRAFENIB;
DAPAGLIFLOZIN;
FARXIGA;
SODIUM GLUCOSE COTRANSPORTER;
TRAMETINIB;
UNCLASSIFIED DRUG;
BASAL CELL CARCINOMA;
BLADDER CANCER;
BLEEDING;
CARDIOMYOPATHY;
DEHYDRATION;
DRUG APPROVAL;
DRUG MECHANISM;
EYE TOXICITY;
FEVER;
FUNGAL GENITAL INFECTION;
GLOMERULUS FILTRATION RATE;
GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY;
GLYCEMIC CONTROL;
HUMAN;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
HYPOTENSION;
INTERSTITIAL LUNG DISEASE;
KERATOACANTHOMA;
KIDNEY FAILURE;
MELANOMA;
MELANOMA SKIN CANCER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SEVERE RENAL IMPAIRMENT;
SKIN TOXICITY;
SQUAMOUS CELL CARCINOMA;
VENOUS THROMBOEMBOLISM;
|
|
EID: 84896440783
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
